Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Jun;51(6):e13501.
doi: 10.1111/eci.13501. Epub 2021 Feb 8.

Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

Affiliations
Comparative Study

Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

Ana P Tedim et al. Eur J Clin Invest. 2021 Jun.

Abstract

Background: The presence of SARS-CoV-2 RNA in plasma has been linked to disease severity and mortality. We compared RT-qPCR to droplet digital PCR (ddPCR) to detect SARS-CoV-2 RNA in plasma from COVID-19 patients (mild, moderate, and critical disease).

Methods: The presence/concentration of SARS-CoV-2 RNA in plasma was compared in three groups of COVID-19 patients (30 outpatients, 30 ward patients and 30 ICU patients) using both RT-qPCR and ddPCR. Plasma was obtained in the first 24h following admission, and RNA was extracted using eMAG. ddPCR was performed using Bio-Rad SARS-CoV-2 detection kit, and RT-qPCR was performed using GeneFinder™ COVID-19 Plus RealAmp Kit. Statistical analysis was performed using Statistical Package for the Social Science.

Results: SARS-CoV-2 RNA was detected, using ddPCR and RT-qPCR, in 91% and 87% of ICU patients, 27% and 23% of ward patients and 3% and 3% of outpatients. The concordance of the results obtained by both methods was excellent (Cohen's kappa index = 0.953). RT-qPCR was able to detect 34/36 (94.4%) patients positive for viral RNA in plasma by ddPCR. Viral RNA load was higher in ICU patients compared with the other groups (P < .001), by both ddPCR and RT-qPCR. AUC analysis revealed Ct values (RT-qPCR) and viral RNA load values (ddPCR) can similarly differentiate between patients admitted to wards and to the ICU (AUC of 0.90 and 0.89, respectively).

Conclusion: Both methods yielded similar prevalence of RNAemia between groups, with ICU patients showing the highest (>85%). RT-qPCR was as useful as ddPCR to detect and quantify SARS-CoV-2 RNAemia in plasma.

Keywords: COVID-19; RNAemia; RT-qPCR; SARS-CoV-2; ddPCR; viral RNA load.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest regarding this submission.

Figures

FIGURE 1
FIGURE 1
Panel (a) Heatmap showing individual results for the presence/absence of SARS‐CoV‐2 RNA in plasma using qPCR or ddPCR. (b) Percentage of SARS‐CoV‐2 RNA in plasma in each group of patients. (c) AUROC analysis to differentiate patients admitted to the ward or to the ICU based on viral load in plasma assessed by RT‐qPCR or ddPCR

Similar articles

Cited by

References

    1. World Health Organization (WHO) . (2020). Weekly epidemiological update‐29. 2020 [cited 2021 Jan 5]. p. 21. Retrieved from: https://www.who.int/publications/m/item/weekly‐epidemiological‐update–‐2...
    1. Rodriguez‐Gonzalez C, Chamorro‐de‐Vega E, Valerio M, et al. COVID‐19 in hospitalized patients in Spain: a cohort study in Madrid. Int J Antimicrob Agents. 2020;57:106249. - PMC - PubMed
    1. Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID‐19: a systematic review and meta‐analysis of observational studies. Anaesthesia. 2020;75:1340‐1349. - PubMed
    1. Chen X, Zhao B, Qu Y, et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) Is closely correlated with drastically elevated interleukin 6 level in critically Ill patients with coronavirus disease 2019. Clin Infect Dis. 2020;71:1937‐1942. - PMC - PubMed
    1. Chen W, Lan Y, Yuan X, et al. Detectable 2019‐nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerging Microbes & Infections. 2020;9:469‐473. - PMC - PubMed

Publication types